Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study-Reference-Cited by-同舟云学术

Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study

Published:2015-04-07 Issue:6 Volume:45 Page:569-575
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Huang Yisheng,Zhang Li,Shi Yuankai,Ma Shenglin,Liao Meilin,Bai Chunxue,Zhang Qingyuan,Wang Changli,Luo Feng,Yu Shiying,Qin Shukui,Zhi Xiuyi,Zhou Caicun

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/45/6/569/14096988/hyv036.pdf

Reference32 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Lung cancer: histology, staging, treatment and survival;Novaes;J Bras Pneumol,2008

3. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

4. EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary;Sant;Ann Oncol,2003

5. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Third Shot at EGFR: New Opportunities in Cancer Therapy;Trends in Pharmacological Sciences;2019-12

2. Rapid onset of conjunctivitis associated with overdosing of erlotinib;Journal of Clinical Pharmacy and Therapeutics;2017-10-25

3. High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases;Journal of Neuro-Oncology;2017-08-05

4. Treatment outcome comparisons between exons 19 and 21 EGFR mutations for non-small-cell lung cancer patients with malignant pleural effusion after first-line and second-line tyrosine kinase inhibitors;Tumor Biology;2017-06

5. Efficacy of Second-line Tyrosine Kinase Inhibitors in the Treatment of Metastatic Advanced Non-small-cell Lung Cancer Harboring Exon 19 and 21 EGFR Mutations;Journal of Cancer;2017